The phenotypic spectrum of PCDH12 associated disorders - Five new cases and review of the literature.

Kirsten Kolzter, Anne Koy, Michael C Kruer, Sebahattin Cirak, Hossein Darvish, Min Ae Lee-Kirsch, Friederike Körber, Sheng Chih Jin, Sajad Shafiee, Walid Fazeli, Anja Weik, Andreas Hahn, Matthias Giersdorf, Abbas Tafakhori, Somayeh Bakhtiari, Abubakar Moawia, Daniel Bamborschke

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2022;36():7-13

PMID: 34773825

Abstract

PCDH12 is a member of the non-clustered protocadherin family of calcium-dependent cell adhesion proteins, which are involved in the regulation of brain development and endothelial adhesion. To date, only 15 families have been reported with PCDH12 associated disease. The main features previously associated with PCDH12 deficiency are developmental delay, movement disorder, epilepsy, microcephaly, visual impairment, midbrain malformations, and intracranial calcifications. Here, we report novel clinical features such as onset of epilepsy after infancy, episodes of transient developmental regression, and dysplasia of the medulla oblongata associated with three different novel truncating PCDH12 mutations in five cases (three children, two adults) from three unrelated families. Interestingly, our data suggests a clinical overlap with interferonopathies, and we show an elevated interferon score in two pediatric patients. This case series expands the genetic and phenotypic spectrum of PCDH12 associated diseases and highlights the broad clinical variability.

Copyright © 2021 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Address: Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Institute for Molecular and Behavioral Neuroscience, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Department of Neuropediatrics, University Hospital Bonn, Bonn, Germany. Electronic address: [email protected].; Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Pediatric Movement Disorders Program, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ, USA; Departments of Child Health, Cellular & Molecular Medicine, and Neurology and Program in Genetics, University of Arizona College of Medicine Phoenix, Phoenix, AZ, USA.; Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.; Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Department of Child Neurology, Justus-Liebig-University Giessen, Giessen, Germany.; CeGAT GmbH and Praxis für Humangenetik Tübingen, Tübingen, Germany.; Children's Hospital Amsterdamer Straße, Kliniken der Stadt Köln, Cologne, Germany.; Neurological Surgery Department, Mazandaran University of Medical Sciences, Sari, Iran.; Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Department of Pediatrics, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; Neuroscience Research Center, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.